101.
Serum IgG2 levels predict long-term protection following pneumococcal vaccination in systemic lupus erythematosus (SLE)
by Gerard, Anne-Laure
Vaccine, 2020-10-14, Vol.38 (44), p.6859-6863
102.
Influenza vaccination as a novel means of preventing coronary heart disease: Effectiveness in older adults
by Aidoud, Amal
Vaccine, 2020-07-06, Vol.38 (32), p.4944-4955
103.
104.
Oral administration of an anti-CfaE secretory IgA antibody protects against Enterotoxigenic Escherichia coli diarrheal disease in a nonhuman primate model
by Stoppato, Matteo
Vaccine, 2020-02-28, Vol.38 (10), p.2333-2339
105.
Quantifying population preferences around vaccination against severe but rare diseases: A conjoint analysis among French university students, 2016
by Seanehia, Joy
Vaccine, 2017, Vol.35 (20), p.2676-2684
106.
A case-control study of risk factors for intussusception among infants in eastern France after the introduction of the rotavirus vaccine
by Fotso Kamdem, Arnaud
Vaccine, 2019-07-26, Vol.37 (32), p.4587-4593
107.
Role of antigen specific T and B cells in systemic and mucosal immune responses in ETEC and Shigella infections, and their potential to serve as correlates of protection in vaccine...
by Mani, Sachin
Vaccine, 2019-08-07, Vol.37 (34), p.4787-4793
108.
Estimation of parameters related to vaccine efficacy and dengue transmission from two large phase III studies
by Coudeville, Laurent
Vaccine, 2015, Vol.34 (50), p.6417-6425
109.
Use of ENABL® adjuvant to increase the potency of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine
by Barrera, José
Vaccine, 2018-02-14, Vol.36 (8), p.1078-1084
110.
Knowledge about vaccines and vaccination in older people: Results of a national survey by the Italian Society for Gerontology & Geriatrics
by Ecarnot, Fiona
Vaccine, 2020-02-05, Vol.38 (6), p.1535-1540
111.
Characterization of whole blood transcriptome and early-life fecal microbiota in high and low responder pigs before, and after vaccination for Mycoplasma hyopneumoniae
by Munyaka, Peris M
Vaccine, 2019-03-22, Vol.37 (13), p.1743-1755
112.
113.
HPV cervical infections and serological status in vaccinated and unvaccinated women
by Murall, Carmen Lía
Vaccine, 2020-12-03, Vol.38 (51), p.8167-8174
114.
Effectiveness of an intervention campaign on influenza vaccination of professionals in nursing homes: A cluster-randomized controlled trial
by Borgey, France
Vaccine, 2019-02-28, Vol.37 (10), p.1260-1265
115.
Strain coverage of Bexsero vaccine assessed by whole-genome sequencing over a cohort of invasive meningococci of serogroups B and W isolated in Switzerland
by Leo, Stefano
Vaccine, 2020-07-14, Vol.38 (33), p.5324-5331
116.
Utility of the Tétanos Quick Stick® in the vaccine catch-up of adult migrants without proof of prior vaccination
by Adeikalam, Sandrine
Vaccine, 2020-11-03, Vol.38 (47), p.7517-7525
117.
Hepatitis A incidence, seroprevalence, and vaccination decision among MSM in Amsterdam, the Netherlands
by Alberts, Catharina J
Vaccine, 2019-05-09, Vol.37 (21), p.2849-2856
118.
Vaccine-preventable diseases other than tuberculosis, and homelessness: A scoping review of the published literature, 1980 to 2020
by Ly, Tran Duc Anh
Vaccine, 2021-02-22, Vol.39 (8), p.1205-1224
119.
Development of a PPRV challenge model in goats and its use to assess the efficacy of a PPR vaccine
by Enchery, François
Vaccine, 2019-03-14, Vol.37 (12), p.1667-1673
120.
Construction and evaluation of Bordetella pertussis live attenuated vaccine strain BPZE1 producing Fim3
by Debrie, Anne-Sophie
Vaccine, 2018-03-07, Vol.36 (11), p.1345-1352
Filter electronic articles 22.079 Hits
Remove Filters
- Journal Title
- Vaccine
- Vaccine 23: 4342-4352 (1)
- Vaccine 26: 4494-4505 (1)
- more ...